<code id='E1B7EA5B9A'></code><style id='E1B7EA5B9A'></style>
    • <acronym id='E1B7EA5B9A'></acronym>
      <center id='E1B7EA5B9A'><center id='E1B7EA5B9A'><tfoot id='E1B7EA5B9A'></tfoot></center><abbr id='E1B7EA5B9A'><dir id='E1B7EA5B9A'><tfoot id='E1B7EA5B9A'></tfoot><noframes id='E1B7EA5B9A'>

    • <optgroup id='E1B7EA5B9A'><strike id='E1B7EA5B9A'><sup id='E1B7EA5B9A'></sup></strike><code id='E1B7EA5B9A'></code></optgroup>
        1. <b id='E1B7EA5B9A'><label id='E1B7EA5B9A'><select id='E1B7EA5B9A'><dt id='E1B7EA5B9A'><span id='E1B7EA5B9A'></span></dt></select></label></b><u id='E1B7EA5B9A'></u>
          <i id='E1B7EA5B9A'><strike id='E1B7EA5B9A'><tt id='E1B7EA5B9A'><pre id='E1B7EA5B9A'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:5327
          Red Blood Cells
          Adobe

          The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

          The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

          advertisement

          Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more
          Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder
          Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

          2:59PoliceofficersworkatthesceneasinvestigationsareongoingthedayafteramassshootingintheKingsessingse

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Pentagon will tighten controls on classified information after Discord leak

          1:38AviewofDepartmentofDefenseinPentagonArlington-Virginia,March14,2023.CelalGunes/AnadoluAgencyviaG